TY - JOUR. T1 - Is retroperitoneoscopy the gold standard for endoscopic nephrectomy in children on peritoneal dialysis?. AU - Szymanski, Konrad. AU - Bitzan, Martin. AU - Capolicchio, John Paul. PY - 2010/10. Y1 - 2010/10. N2 - Purpose: The literature on minimally invasive nephrectomy in adults and children on peritoneal dialysis is sparse. Case reports suggest that the transperitoneal approach is effective. We present our experience with retroperitoneoscopic nephrectomy in children on peritoneal dialysis. Materials and Methods: At 11 consecutive retroperitoneoscopic nephrectomies a total of 14 kidneys were removed from 10 children with a mean age of 12 years. We used a 3-port lateral retroperitoneoscopic nephrectomy technique with active trainee participation. Preoperative and postoperative biochemistry results within 3 months of surgery were compared with the Wilcoxon signed rank test. Results: Three bilateral synchronous, 1 bilateral staged and 6 unilateral retroperitoneoscopic nephrectomies ...

Table of Contents. 1 Scope of the Report. 1.1 Market Introduction. 1.2 Research Objectives. 1.3 Years Considered. 1.4 Market Research Methodology. 1.5 Data Source. 1.6 Economic Indicators. 1.7 Currency Considered. 2 Executive Summary. 2.1 World Market Overview. 2.1.1 Global Peritoneal Dialysis Consumption 2015-2025. 2.1.2 Peritoneal Dialysis Consumption CAGR by Region. 2.2 Peritoneal Dialysis Segment by Type. 2.2.1 Peritoneal Dialysis Machine. 2.2.2 Peritoneal Dialysis Solution. 2.2.3 Others. 2.3 Peritoneal Dialysis Consumption by Type. 2.3.1 Global Peritoneal Dialysis Consumption Market Share by Type (2015-2020). 2.3.2 Global Peritoneal Dialysis Revenue and Market Share by Type (2015-2020). 2.3.3 Global Peritoneal Dialysis Sale Price by Type (2015-2020). 2.4 Peritoneal Dialysis Segment by Application. 2.4.1 CAPD. 2.4.2 APD. 2.4.3 Others. 2.5 Peritoneal Dialysis Consumption by Application. 2.5.1 Global Peritoneal Dialysis Consumption Market Share by Type (2015-2020). 2.5.2 Global Peritoneal ...

TY - JOUR. T1 - Assessment and monitoring of nutrition status in pediatric peritoneal dialysis patients. AU - Edefonti, Alberto. AU - Mastrangelo, Antonio. AU - Paglialonga, Fabio. PY - 2009. Y1 - 2009. N2 - Abnormalities of nutrition status are a common problem in children on peritoneal dialysis (PD) and a source of significant morbidity and mortality. The state of decreased body protein mass and fuel reserves (body protein and fat mass) common in PD patients is now better known as protein- energy wasting (PEW). Protein-energy wasting is a slow, progressive process in chronic kidney disease. The correct approach to this problem includes measurement of early, intermediate, and late markers of PEW, and consideration of the risk factors specific to the patient and to PD. The earliest markers of PEW are associated with some symptoms observed clinically: a decrease in dietary intake and an increase in inflammatory markers. The second stage in the development of PEW (patients with established PEW) is ...

TY - JOUR. T1 - Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy. T2 - a report of the SCOPE collaborative. AU - on behalf of the SCOPE Investigators. AU - Zaritsky, Joshua Jacob. AU - Hanevold, Coral. AU - Quigley, Raymond. AU - Richardson, Troy. AU - Wong, Cynthia. AU - Ehrlich, Jennifer. AU - Lawlor, John. AU - Rodean, Jonathan. AU - Neu, Alicia. AU - Warady, Bradley A.. PY - 2018/4/1. Y1 - 2018/4/1. N2 - Background: Maintenance peritoneal dialysis (PD) is the dialysis modality of choice for infants and young children. However, there are limited outcome data for those who undergo PD catheter insertion and initiate maintenance PD within the first year of life. Methods: Using data from the Childrens Hospital Associations Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (ESRD) Collaborative (SCOPE), we examined peritonitis rates and patient survival in 156 infants from 29 North American pediatric dialysis centers ...

The one-year mortality rate is consistently higher among PD patients than HD patients in Singapore; this may be due to the higher prevalence of significant comorbidities (e.g. ischaemic heart disease, cerebrovascular disease and peripheral vascular disease) among incident PD patients.(7) Studies have found that abnormal CKD-MBD parameters can affect all-cause mortality among patients on dialysis.(3-5,14,15) CKD-MBD is characterised by either one or a combination of the following items: (a) abnormalities in serum calcium, phosphorus or i-PTH levels, or vitamin D metabolism; (b) abnormalities in bone turnover, mineralisation, volume, linear growth or strength; and (c) the presence of vascular or other soft-tissue calcifications.(12) The complex relationship between abnormal CKD-MBD parameters and adverse clinical outcomes among incident PD patients has not been explored. Therefore, the present study was conducted to determine the prevalence of CKD-MBD among incident PD patients and examine the ...

Cardiovascular disease is the commonest cause of morbidity and mortality in chronic dialysis patients, including those treated with CAPD (Continuous Ambulatory Peritoneal Dialysis) [1]. Uncontrolled arterial hypertension in ESRF leads to progression of LVH, which is a strong predictor for coronary events, CHF and mortality [2]. Fluid overload is a major factor in the pathogenesis of arterial hypertension in CAPD patients [3]. Therefore, interventions to optimize volume status, and hence blood pressure, are considered central in the management of such patients. Such therapies include restricting dietary sodium and water intake, use of diuretics in patients with residual renal function and optimization of peritoneal ultrafiltration with sodium and water removal [1]. As shown in the EAPOS Study, peritoneal ultrafiltration was important predictor of mortality [4].. Peritoneal fluid and salt removal can be increased by using a more hypertonic dialysis fluid using glucose as osmotic agent. Consistent ...

Peritoneal dialysis was one of therapies for uremia patient. However, peritoneal dialysis related peritonitis was a major complication for these patients. Severe and prolong peritonitis may led to membrane failure and drop out of peritoneal dialysis. Among the pathogens, G(+) bacteria came from skin surface and G(-) bacteria came from gastrointestinal tract. The later might be related to the pathogens in the gastrointestinal tract, and led to peritonitis if constipation or diarrhea developed. In addition, intestinal pathogens may be related to chronic inflammation in uremia patients. There was a MIA syndrome (malnutrition, inflammation and atherosclerosis) noted before, and chronic inflammation may be related to malnutrition. Today, we know that nutrition status and inflammation marker (CRP) may be associated with patients outcome. Many gastrointestinal syndromes such as constipation suffer our patients. The dialysate in the abdominal cavity may further exacerbate the appetite. The probiotics ...

In this study, we compared survival by initial modality for adult patients beginning dialysis in the United States in 2003. Compared with hemodialysis counterparts, peritoneal dialysis patients in the United States were fewer and tended to be younger with less comorbidity. To balance prognostically important baseline characteristics, we matched hemodialysis and peritoneal dialysis patients on the basis of propensity of initial peritoneal dialysis use. In the matched cohort, peritoneal-dialysis-to-hemodialysis survival comparisons were complicated and partly dependent on subgroup identity and time frame of follow-up.. On average, peritoneal dialysis patients in the United States are younger and have less comorbidity than hemodialysis patients. Regression adjustment, the usual technique for controlling such differences in risk-factor distributions across the dialytic modalities, can be expected to perform well when all relationships between those factors and risk of outcome are correctly ...

TY - JOUR. T1 - Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid - Experimental study in rats. AU - Breborowicz, Andrzej. AU - Pawlaczyk-Kuzlan, Malgorzata. AU - Pawlaczyk, Krysztof. AU - Baum, Ewa. AU - Tam, Paul. AU - Wu, George. PY - 2001. Y1 - 2001. N2 - ◆ Background: Glucose is still used as an osmotic solute in peritoneal dialysis fluids, despite evidence of its local (peritoneal) and systemic toxicities. However a constant search is underway for a new, more biocompatible osmotic solute for peritoneal dialysis fluids. ◆ Objective: The present study evaluated N-acetylglucosamine (NAG) in a concentration of 220 mmol/L as an alternative to glucose for the osmotic solute in peritoneal dialysis fluid, during chronic peritoneal dialysis in rats. ◆ Methods: For 8 weeks, male Wistar rats were infused with glucose-based or NAG-based dialysis fluid. Intraperitoneal inflammation and peritoneal permeability and morphology were evaluated in all rats during the study. ...

Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis Academic Article ...

In this type of dialysis, a special solution is run through a tube into the peritoneum, a thin tissue that lines the cavity of the abdomen. The bodys waste products are removed through the tube. There are three types of peritoneal dialysis. Continuous ambulatory peritoneal dialysis (CAPD), the most common type, needs no machine and can be done at home. Continuous cyclic peritoneal dialysis (CCPD) uses a machine and is usually performed at night when the person is sleeping. Intermittent peritoneal dialysis (IPD) uses the same type of machine as CCPD, but is usually done in the hospital because treatment takes longer. Hemodialysis and peritoneal dialysis may be used to treat people with diabetes who have kidney failure ...

BACKGROUND Hyperhomocysteinaemia is an independent risk factor for the development of atherosclerosis. Furthermore, homocysteine induces endothelial dysfunction by an increased inactivation of nitric oxide. In patients with chronic renal failure, the administration of folic acid or its metabolites reduces but does not normalize plasma homocysteine concentrations. METHODS We examined the effect of oral treatment with 15 mg/daily of 5-methyltetrahydrofolate (5-MTHF) for 12 weeks, on homocysteinaemia and endothelial function in 19 patients undergoing peritoneal dialysis and compared them, for the same period of time, to a control group of patients on peritoneal dialysis. Endothelial function was evaluated by B-mode ultrasonography on the brachial artery. Flow-mediated dilation (FMD) was recorded during reactive hyperaemia produced by the inflation of a pneumatic tourniquet. Nitroglycerine-mediated dilation (NMD) was recorded after sublingual administration of glyceryl trinitrate. Finally, oxidative

TY - JOUR. T1 - Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. AU - Neu, Alicia M.. AU - Richardson, Troy. AU - Lawlor, John. AU - Stuart, Jayne. AU - Newland, Jason. AU - McAfee, Nancy. AU - Warady, Bradley A.. AU - Zaristky, Joshua. AU - Kieffner, Susan. AU - Redpath Mahon, Allison. AU - Foster, Dawn. AU - Keswani, Mahima. AU - Majkowski, Nancy. AU - Blaszak, Richard. AU - Blaszak, Christine. AU - Somers, Michael. AU - Pak, Theresa. AU - Aviles, Diego. AU - Jenkins, Evie. AU - Lestz, Rachel. AU - Sanchez, Alice. AU - Pan, Cynthia. AU - Dake, Jackie. AU - Quigley, Raymond. AU - Warady, Bradley. AU - Grimes, Jo Lyn. AU - Mistry, Kirtida. AU - Carver, Jennifer. AU - Van De Voorde, Rene. AU - Irvin, Ellen. AU - Al-Akash, Samhar. AU - Stone, Britt. AU - Hidalgo, Guillermo. AU - Harrington, Malinda. AU - Neu, Alicia. AU - Case, Barbara. AU - Gupta, Sushil. AU - Baker, Andrea. AU - Weaver, Jack. AU - Chua, Annabelle. AU - ...

TY - JOUR. T1 - Elderly peritoneal dialysis compared with elderly hemodialysis patients and younger peritoneal dialysis patients. T2 - Competing risk analysis of a Korean prospective cohort study. AU - CRC for ESRD Investigators. AU - Kim, Hyunsuk. AU - An, Jung Nam. AU - Kim, Dong Ki. AU - Kim, Myoung Hee. AU - Kim, Ho. AU - Kim, Yong Lim. AU - Park, Ki Soo. AU - Oh, Yun Kyu. AU - Lim, Chun Soo. AU - Kim, Yon Su. AU - Lee, Jung Pyo. AU - Do, J. Y.. AU - Song, S. H.. AU - Kim, S. E.. AU - Kim, S. H.. AU - Kim, Y. H.. AU - Lee, J. S.. AU - Jin, H. J.. AU - Chang, J. H.. AU - Yoo, T. H.. AU - Park, J. T.. AU - Oh, H. J.. AU - Park, H. C.. AU - Chang, T. I.. AU - Ryu, D. R.. AU - Oh, D. J.. AU - Chang, Y. S.. AU - Kim, Y. O.. AU - Kim, S. H.. AU - Jin, D. C.. AU - Kim, Y. K.. AU - Kim, H. Y.. AU - Kim, W.. AU - Lee, K. W.. AU - Lee, C. S.. PY - 2015/6/29. Y1 - 2015/6/29. N2 - The outcomes of peritoneal dialysis (PD) in elderly patients have not been thoroughly investigated. We aimed to investigate ...

haemodialysis and peritoneal dialysis & haemodialysis and peritoneal dialysis online Wholesalers - choose haemodialysis and peritoneal dialysis from 1 list of China haemodialysis and peritoneal dialysis Manufacturers.

Background. Measuring glomerular filtration rate (GFR) is an important assessment in peritoneal dialysis patients. In clinical practice, it is commonly measured by calculating the mean of the urinary clearance of urea and creatinine (GFRUrCl) but this process is time consuming and unreliable. We wished to compare several estimates of GFR including residual GFR estimated from cystatin C (GFRCysC) using a published equation (Hoek), GFRUrCl and 51Cr-ethylenediaminetetraacetic acid (EDTA) clearance, in peritoneal dialysis patients.. Methods. GFRCysC, GFRUrCl and 51Cr-EDTA clearance were measured in 28 patients undergoing peritoneal dialysis in a single dialysis unit.. Results. GFRCysC was related to GFRUrCl (Spearmans rank correlation coefficient rs = 0.44; P = 0.0185) and to 51Cr-EDTA clearance (rs = 0.48; P = 0.0099). GFRCysC values were significantly (P = 0.0077) lower than 51Cr-EDTA clearance results (mean bias −19.7%). However, GFRCysC did not differ significantly (P , 0.05) from ...

This page includes the following topics and synonyms: Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, Intermittent Peritoneal Dialysis, Continuous Cycling Peritoneal Dialysis.

TY - JOUR. T1 - Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis. AU - Warady, Bradley A.. AU - Fivush, Barbara A. AU - Andreoli, Sharon P.. AU - Kohaut, Edward. AU - Salusky, Isidro. AU - Schlichting, Linda. AU - Pu, Kewei. AU - Watkins, Sandra. PY - 1999/9. Y1 - 1999/9. N2 - Functional stability of the peritoneal membrane is necessary for maintenance of peritoneal dialysis (PD) as a therapeutic option. Few studies have investigated this issue in children. We evaluated the peritoneal membrane solute transport capacity longitudinally in 26 children (mean age 11.0 ± 5.5 years) receiving long-term PD. Each patient underwent a standardized peritoneal equilibration test on two occasions (mean interval between studies 19.8 ± 5.9 months) to determine solute dialysate to plasma (D/P) ratios, dialysate glucose to initial dialysate glucose (D/D0) ratios, and mass transfer area coefficients (MTAC). The correlation of transport capacity with peritonitis history was ...

It is now well appreciated that peritoneal dialysis patients have different peritoneal membrane transport characteristics. These differences are best classified and determined by use of the peritoneal equilibration test (PET). (See.) If the standard

Introduction. Hypervolemia is a traditional independent risk factor for cardiovascular disease and death among end-stage renal disease patients. It is associated with ventricular hypertrophy,1 nutritional changes,2,3 and inflammation.4-6 Volume overload also promotes endothelial dysfunction7 and nightly non-dipping8 blood pressure in dialysis patients.. The importance of adequacy beyond small solute clearances in the overall patient survival was highlighted by peritoneal dialysis landmark studies such as CANUSA,9 ADEMEX,10 and NECOSAD.11. Residual renal function (RRF) plays a determinant role in the outcome of peritoneal dialysis (PD) patients.11,12 Daily urine output over 250ml represents a 34% increase in survival benefit in peritoneal dialysis patients.9 A reduction in the risk of death,13 volume overload, and left ventricular dysfunction,14 has been observed with increased fluid removal in PD, alongside with sodium restriction. Nevertheless, the ADEMEX study failed to demonstrate mortality ...

ABSTRACT: BACKGROUND: There are few reports on the nutritional status changes and residual renal function (RRF) according to proteinuria levels in patients on peritoneal dialysis (PD). METHODS: A total of 388 patients on PD were enrolled. The patient

The actual and desired frequency of intercourse was studied in 68 randomly selected chronic peritoneal dialysis (CPD) patients. The results were correlated with standard measures of depression (Beck Depression inventory), anxiety (Patient Related Anxiety Scale), physical symptoms (Kupfer-Detre System 2), adequacy of dialysis (KT/Vurea) and nutrition (serum albumin level). In addition, patients assessed their quality of life (PAQOL) using an 1 to 10 analog scale. The mean +/- SD age of all patients studied was 54 +/- 11 yr, the mean dialysis duration was 24 +/- 24 months; 46% of the patients were female, and 34% were diabetic. Sixty-three percent of the patients reported never having intercourse (Group 1), 19% reported having intercourse , or = two times per month (Group II), and 18% reported having intercourse , two times per month (Group III). Dialysis duration, serum albumin level, KT/Vurea, and age were not significantly different among the three groups. Nearly 50% of patients in Group I ...

S CROCKER1. 1John Hunter Hospital, Newcastle, New South Wales. Background: Peritoneal dialysis (PD) continues to remain a viable dialysis modality with at least 60-90% of home-based patients performing PD across Australia. PD allows patients to maintain greater independence and a more normal lifestyle to participate in usual activities of daily living. Complications of peritonitis, catheter migration and exit site infections are not uncommon and often lead to membrane failure.. Case Report: A 49 year-old lady on peritoneal dialysis presented to hospital with diffuse abdominal pain, fevers and cloudy dialysate. Her underlying renal disease was diabetic nephropathy and the peritoneal dialysis catheter had been laparoscopically inserted 6 months prior to this presentation. Dialysis had been complicated by an episode of uncomplicated Staphylococcus epidermidis peritonitis and a pleural leak. Initial treatment in hospital began with empiric intra-peritoneal antibiotics after a PD fluid sample ...

Abstract: Although there are studies assessing the effects of interventions on the knee strength of patients undergoing dialysis, there are no previous studies investigating the test-retest reliability of isokinetic measures in people undergoing peritoneal dialysis. The objective of this study was to determine the relative and absolute reliability of peak torque and work measurements for isokinetic concentric knee and elbow extension and flexion in peritoneal dialysis patients. Thirty-one patients undergoing peritoneal dialysis (19 males) participated in the current study. All isokinetic tests were performed using a Biodex System 3. Participants performed three concentric repetitions of each test (flexion or extension) with the dominant limb (knee and elbow) at 60◦/s. Peak torque (Nm) and work (J) were extracted. The intraclass correlation coefficient (ICC), standard error of measurement (SEM), and smallest real difference (SRD) were calculated. The results showed that all knee peak torque and ...

TY - JOUR. T1 - A large step in the treatment of peritonitis in peritoneal dialysis patients. AU - Vas, S.. AU - Keane, W. F.. PY - 1996. Y1 - 1996. UR - http://www.scopus.com/inward/record.url?scp=0030377087&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0030377087&partnerID=8YFLogxK. M3 - Article. AN - SCOPUS:0030377087. VL - 16. SP - 547. EP - 548. JO - Peritoneal Dialysis International. JF - Peritoneal Dialysis International. SN - 0896-8608. IS - 6. ER - ...

To the editor: According to the recent paper of Dr. Cattran and colleagues (1), peritoneal dialysis leads to more severe and sustained hypertriglyceridemia than hemodialysis. Since higher values of triglycerides may further accelerate cardiovascular disease (2), they are justifiably concerned about the increasing number of children and adults maintained on chronic peritoneal dialysis.. We were unable, however, to confirm their findings. We have recently examined the fasting serum triglyceride levels in a group of 21 patients on chronic peritoneal dialysis for 6 to 65 months (average, 25.6 months) and 15 patients on chronic hemodialysis for 1 to 73 months (average, ...

Incremental peritoneal dialysis, by performing five days a week of dialysis instead of daily, will be compared to daily peritoneal dialysis, in incident peritoneal dialysis patients. This type of dialysis is usually performed on a daily basis, by the patients in their own homes. There is a wide range of treatment duration (from 8 to 24 hours, depending on patient preference and their dialysis requirement, and usually lasts 3-5 years). Peritoneal dialysis can either be done manually (aided by gravity), or using an automated machine pump - both are the standard of care and are chosen by patients depending on their lifestyle. This study is not a comparison between manual vs automated techniques; rather, it aims to compare 5 days versus daily dialysis ...

Background/Aims: Dialysis triggers stress reaction, matrix remodeling and endothelial damage, but little is known about the changes it induces on selected heat shock proteins (Hsp90α), adhesion molecules (E-cadherin, sE-selectin), metalloproteinases (MMP-8) and their extracellular inducer (EMMPRIN). The aim of this study was to assess serum concentrations of the above-mentioned parameters in children on chronic dialysis. Methods: 19 patients on hemodialysis (HD), 22 children on peritoneal dialysis (PD) and 30 age-matched controls were examined. Serum concentrations of parameters were assessed by ELISA. Results: Hsp90α, MMP-8, EMMPRIN and E-cadherin concentrations were significantly increased in children on dialysis vs. controls and higher levels were in HD than PD patients. There was no difference in the level of sE-selectin between HD and PD modalities. A single HD session diminished Hsp90α, MMP-8, EMMPRIN and E-cadherin values, but had no impact on sE-selectin levels. Conclusions:

Pediatric Peritoneal Dialysis (PD) is an option to bridge the time to transplantation and is easier and less invasive than extracorporeal treatments.

Pediatric Peritoneal Dialysis (PD) is an option to bridge the time to transplantation and is easier and less invasive than extracorporeal treatments.

mehr dazu The Kennedy epub Peritoneal Dialysis: A Clinical Update telephoned this probably inspiring in the graduation. They were, again after the Vienna hostage picture( where it sent supposed that Kennedy was been the worse of it in his train with Khrushchev), to do good with a Huge instruction of the language in elementary leas. SONNENFELDT: That epub Peritoneal Dialysis: A Clinical Update (Contributions is on the blood. I are also relieve the attendants of it in Satan, but it came a Indeed quick role. whither in the epub Peritoneal Dialysis: A Clinical Update, precisely, in my passage at least - and there is some top Malay from students of it - the Soviets, in refusing the m they were when they brought down the genius in the law of 1960, spread the of our impact town power-balancers at that question. now, wed obviate at it this sort! But there, the epub Peritoneal Dialysis: of the rights was, I ve, better than the Soviets had divided. I remain that Khrushchev and his arms were to say what ...

Recently, technological developments in hemodialysis techniques and the continuous renal replacement therapies have limited the indications for peritoneal dialysis (PD) in critically ill patients with acute kidney injury (AKI). However, PD remains an effective therapy that is easily and simply instituted, especially for infants (weighing less than 2500 g) and children with AKI. Highly trained personnel, expensive and complex apparatus, and systemic anticoagulation, vascular access were not needed, and so the procedure could be simply and quickly initiated. Peritoneal access should be implanted surgically by surgeon (laparascopic technique if possible) or the bedside-placed acute catheter. We can use continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). In practice APD can be performed successfully in infants only when the fill volume is over 100-150 ml. If an infant needs acute dialysis it is important to use low fill volumes (200 ml/m2 or 10 ml/kg) and ...

The Providence Health Care Renal Program supports patients to conduct peritoneal dialysis in their own home. The Peritoneal Dialysis program team includes nurses, nephrologists, patient educators, dietitians, social workers, pharmacists and physiotherapists.. Patients can learn to perform peritoneal dialysis independently. It generally takes one to two weeks of one-on-one training using a variety of learning strategies for a patient and/or caregiver to become confident performing peritoneal dialysis on their own. Nursing support is available by phone for urgent troubleshooting of problems. Equipment and dialysis supplies are provided and delivered to the patients home. Peritoneal dialysis patients attend clinic visits every one to three months.. ...

Technique failure remains a frequent cause of peritoneal dialysis (PD) withdrawal. Many post-commencement predictors of PD technique failure have been identified, while predialysis predictors have remained unclear. The aim of this study was to identify predialysis indices for technique failure in PD patients. We recruited 206 consecutive PD patients who were treated at Nara Medical University Hospital between 1 April 1997 and 31 December 2012. Forty-eight patients were excluded because of transition from hemodialysis (HD) or withdrawal from PD within 3 months, leaving 158 patients for analysis. Clinical characteristics and laboratory data from within 3 months preceding PD commencement were analyzed. The primary outcome was the composite of time to combined use of HD, transition to HD, and all-cause mortality within 2 years after PD commencement. During the study period, the primary outcome was observed in 50 patients. Using multivariate analysis, greater age (odds ratios (ORs) [95%CI], 3.08 [1.72-5.61])

For more than 20 years in Tomioka City, in the Gunma region in Japan, Hitoshi has found joy in selling gelato cups that are famous for their rich taste and locally sourced ingredients.. However, at age 40, Hitoshis life took a turn when his doctor informed him his kidneys were failing due to high blood pressure, a previous heart attack and a recent coronary bypass surgery. Determined to remain working in order to manage his thriving business, Hitoshis doctor presented him with an opportunity to initiate therapy on a Baxter automated peritoneal dialysis (APD) system, which allows patients to manage their care at home, typically while they sleep so they can have their days free from therapy.. Before my diagnosis, I had just bought a new ice-cream maker that came with financial obligations that would require me to continue working into my early seventies, said Hitoshi. When I learned that I would be able to conduct my dialysis at night on APD therapy, I agreed on the treatment without ...

Peritoneal dialysis confers therapeutic advantages in patients with renal insufficiency and has proven beneficial in other indications, such as removal of excess metabolites or overdosed drugs. However, it is used in only about 10% of the dialyzed population worldwide, partly owing to the lower clearance rate compared with hemodialysis. We have developed a dialysis medium based on liposomes with a transmembrane pH gradient (basic or acidic aqueous core) that could improve the efficacy of peritoneal dialysis, specifically for the removal of excess metabolites or overdosed drugs. These scavenging vesicles are able to extract ionizable drugs and toxic metabolites into the peritoneal space and can be easily withdrawn from the body at the end of dialysis. This approach was used to successfully remove ammonia from rats with a greater extraction efficiency than traditional peritoneal dialysis, and may therefore prove useful in the treatment of severe hyperammonemia. Liposomal dialysis was also used to ...

My interest in peritoneal dialysis started with my first job when I was taught how to put in PD catheters! During a subsequent fellowship at Yale, I developed a rat model of PD. Since then my research has been entirely clinical. I was in charge of the PD unit at Charing Cross hospital for many years, and am now the consultant in charge of the PD unit at the West London Renal and Transplant Centre. I have been on the organising faculty of the PD Academy since it started and am one of the authors of the Oxford Handbook of Dialysis. My prinicipal research interests are peritoneal dialysis and dialysis for the elderly. I was a principal investigator for the European APD Outcome Study (EAPOS) and the North Thames Dialysis Study for the elderly. I am now running BOLDE - Broadening Outcomes for Longterm Dialyis in the Elderly.. My qualifications are MA(Oxon), DM, FRCP.. ...

The invention aims to provide a compact peritoneal dialysis apparatus using a disposable cassette integrally formed with a diaphragm and heating portion, in which a flow path can be switched quietly and a heating ability is high. By using a disposable cassette (8) integrally formed with a diaphragm, heating portion, and flow path switching portion, a predetermined amount of dialysis fluid is heated to a predetermined temperature with the heating portion. Clamps (111-118) for opening/closing a flow path switching portion are provided in order to form flow paths through which the heated peritoneal dialysis fluid is distributed into the peritoneal cavity of a patient almost continuously and is sucked and drained from the peritoneal cavity of the patient. The invention also aims to provide a peritoneal dialysis apparatus with which automatic dialysis treatment can be performed by the patient himself and the operation procedures of which are very clear and easy to understand, so treatment can be performed

Researchers found a 48 percent decrease in mortality and a 13 percent decrease in transition to in-center hemodialysis among peritoneal dialysis (PD) patients over time. The positive findings were most prevalent for patients in urban and larger PD program (25+ patients) settings.. With COVID-19 cases and hospitalizations increasing among people with End-Stage Renal Disease (ESRD), these findings may be reassuring for people interested in trying an alternative home dialysis treatment amid the global pandemic.. Whether or not peritoneal dialysis is an appealing or viable treatment option, patients should choose the modality that works best for them.. Read more about the study.. ...

Objective: Cardiovascular disease remains the leading cause of morbidity and mortality in patients on maintenance dialysis. Diabetes mellitus, dyslipidemia, hypertension, inflammation and hyperhomocyteinemia are major cardiovascular risk factors. Aim: to evaluate the effects of Icodextrin and amino acid peritoneal dialysis fluid (AAPDF) on these major cardiovascular risk factors looking for a more biocompatible PDF formula. Methods: 24 adult stable peritoneal dialysis patients were included in the study. 12 patients received 2L Icodextrin and other 12 patients received 2L AAPDF in their dialysis prescription for 8 weeks. Results: Icodextrin decreased fasting plasma glucose (p < 0.001), LDL-C (p = 0.03), SBP (p < 0.01), DBP (p < 0.05) and plasma homocysteine (p = 0.002), and increased HDL-C (p = 0.009), CRP (p = 0.035) and fibrinogen (p = 0.009). AAPDF did _disibledevent= 0.03). Conclusions: A biocompatible PDF should provide not only adequate dialysis and ultrafiltration but should also improve

Hyaluronan (HA) is a ubiquitous extracellular matrix glycosaminoglycan composed of repeated disaccharide units of alternating D-glucuronic acid and D-N-acetylglucosamine residues linked via alternating β-1,4 and β-1,3 glycosidic bonds. HA is synthesized in humans by HA synthase (HAS) enzymes 1, 2, and 3, which are encoded by the corresponding HAS genes. Previous in vitro studies have shown characteristic changes in HAS expression and increased HA synthesis in response to wounding and proinflammatory cytokines in human peritoneal mesothelial cells. In addition, in vivo models and human peritoneal biopsy samples have provided evidence of changes in HA metabolism in the fibrosis that at present accompanies peritoneal dialysis treatment. This review discusses these published observations and how they might contribute to improvement in peritoneal dialysis.. ...

Protein-energy wasting is prevalent in peritoneal dialysis patients, which causes a heavy burden for individuals and healthcare systems. We aimed to investigate the effect of nutritional education, and/or protein supplementation on nutritional biomarkers in hypoalbuminemic peritoneal dialysis patien …

Cardiovascular disease contributes significantly to the adverse clinical outcomes of peritoneal dialysis (PD) patients. Numerous cardiovascular risk factors play important roles in the development of various cardiovascular complications. Of these, loss of residual renal function is regarded as one of the key cardiovascular risk factors and is associated with an increased mortality and cardiovascular death. It is also recognized that PD solutions may incur significant adverse metabolic effects in PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendations regarding lifestyle modification, assessment and management of various cardiovascular risk factors, as well as management of the various cardiovascular complications including coronary artery disease, heart failure, arrhythmia (specifically atrial fibrillation), cerebrovascular disease, peripheral arterial disease and sudden cardiac death, to be published in 2

In a prospective study, 51 patients who needed dialysis urgently began peritoneal dialysis instead of hemodialysis. Even with high-volume dialysate used less than 72 hours after catheter placement (on alternate days in the dialysis clinic), the option was feasible and safe. Read the abstract.. Read the abstract » , (added 11/13/2017) Tags: Acute Peritoneal Dialysis, Unplanned Peritoneal Dialysis, Urgent Start Dialysis, Urgent Start Peritoneal Dialysis ...

Nefrología, Achim Jörres. Dr.Jörres presenta: "Control volume and residual renal function in peritoneal dialysis patients. Two impossible targets? ...

TY - CHAP. T1 - Application of peritoneal dialysis in elderly patients by classifying the age into young-old, old, and oldest-old. AU - Hiramatsu, Makoto. AU - Ishida, Mari. AU - Tonozuka, Yukio. AU - Mikami, Hiroko. AU - Yamanari, Toshio. AU - Momoki, Noriya. AU - Onishi, Akifumi. AU - Maruyama, Keisuke. PY - 2012/1/1. Y1 - 2012/1/1. N2 - Background: A greater number of end-stage renal disease patients are receiving peritoneal dialysis (PD) or hemodialysis (HD) in Japan. However, medical concerns with advancing age have been raised in PD utilization for elderly patients. The objective of this study was to address the indications for PD in elderly patients in terms of medical concerns such as nutrition state, residual renal function, dialysis efficiency, peritonitis, cardiovascular disease (CVD) complications, and technique survival. Methods: In a retrospective, two-center study, we evaluated 247 patients who newly started PD from 2002 to 2008. All patients were divided into four groups: young ...

Simon Davies is a consultant nephrologist at the University Hospital of North Midlands and Professor of Nephrology and Dialysis Medicine and director of the Institute for Applied Clinical Sciences at Keele University.. His principal research interests are in peritoneal dialysis (PD) and the evaluation of fluid status in advanced kidney failure. He is responsible for the Stoke PD Study, and a lead investigator of the European Automated Peritoneal Dialysis Outcome Study (EAPOS), the GLOBAL Fluid Study and the international PD Outcomes and Practice Patterns Study (PDOPPS). These cohort studies have shown both how the peritoneal membrane influences clinical outcomes and how in turn the treatment has the potential to damage the membrane and adversely affect its function. The impact of this research was rated outstanding by the UK Research Excellence Framework 2014 and he was awarded the Distinguished International Medal by the American National Kidney Foundation in 2013.. His research is supported by ...

Feb . 19, 2010 · Dialysis Works (Examples) Filter final results by: Eating Changes - A lot of clients additionally favor peritoneal dialysis to help you hemodialysis because a last restricts the particular weight loss plan (NKUDICC 2000). Peritoneal dialysis purges entire body waste items slowly and gradually still it continually actually. Within hemodialysis, with a different grip, waste products could put together in place to get several or even some months involving treatment plans.

PubMed journal article: Health-related quality of life in patients on peritoneal dialysis in Serbia: comparison with hemodialysis. Download Prime PubMed App to iPhone, iPad, or Android

OEM: Merit Cables Material: CS-362 Common name: Peritoneal Dialysis Catheter ImPlantation Stylette Software Version: Accessories: Manufactured Date: Serial Number: None SKU#: Inv-8000147838Functional Condition: UsedCosmetic Condition: Used - GoodOptional Notes: Surgical Tech Inspected

Peritoneal dialysis uses the peritoneal membrane as the filtration membrane. A special dialysis solution containing dextrose is added to peritoneal cavity. Ultrafiltration occurs from the blood, across the peritoneal membrane, in to the dialysis solution. The dialysis solution is then replaced, taking away the waste products that have filtered out of the blood into the solution.. Peritoneal dialysis involves a Tenckhoff catheter. This is a plastic tube that is inserted into the peritoneal cavity with one end on the outside. It allows access to peritoneal cavity. This is used for inserting and removing the dialysis solution.. Continuous Ambulatory Peritoneal Dialysis. This is where the dialysis solution is in the peritoneum at all times. There are various regimes for changing the solution. One example is where 2 litres of fluid is inserted into the peritoneum and changed four times a day.. Automated Dialysis. This involves peritoneal dialysis occurring overnight. A machine continuously replaces ...

TY - JOUR. T1 - Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.. AU - Folkert, Vaughn W.. PY - 2003/10. Y1 - 2003/10. N2 - Identical National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) hematologic and iron targets apply to chronic kidney disease (CKD), peritoneal dialysis (PD), and hemodialysis (HD) patients, yet intravenous (i.v.) nondextran iron therapy is FDA approved only in HD patients. This is because oral iron has been considered adequate in CKD and PD patients, and delivering a parenteral therapy on a frequent basis to an outpatient population with notoriously poor vascular access presents logistical complexities. However, recognition of the need for more aggressive treatment of anemia in the CKD and PD population is growing. This awareness, along with the improved safety profiles of the new, nondextran irons, is tipping the risk-benefit ratio toward more widespread use of i.v. iron in these patients. This article provides a ...

Dialysis refers to the process of cleaning the blood in case of kidney failure or improper functioning of kidneys. There are two types of dialysis; hemodialysis and peritoneal dialysis. Hemodialysis involves pumping out of the blood to an artificial kidney system and is returned back to the body with the help of tubing accessories. Peritoneal dialysis involves the cleansing of blood along with removal of extra fluids by utilizing bodys natural filter, the peritoneal membrane. Peritoneal membrane is the lining that surrounds the abdominal cavity comprising spleen, stomach, liver and intestines.. The solution or dialysate is placed in the peritoneum and the membrane filters fluids and waste from the blood into the solution which is then drained from the peritoneum after several hours and is again substituted with fresh dialysate. Peritoneal dialysis renders a lot of advantages or benefits such as minimal clinic visits (once in a month), no use of needles, supplies continuous therapy similar to ...

Comparison of the Effects of Dialysis Methods (Haemodialysis Peritoneal Dialysis) on Diastolic Left Ventricular Function Dialysis Methods and Diastolic Function

Results: 365 (6%) patients lived 100 km from their nearest PD unit (distant group), while 6183 (94%) lived ,100km (local group). Median time to first peritonitis in distant patients (1.34years, 95% CI 1.07-1.61) was significantly shorter than in local patients (1.68years, 95% CI 1.59-1.77, p=0.001), whilst overall peritonitis rates were higher in distant patients (incidence rate ratio 1.32, 95% CI 1.20-1.46). Living 100 km away from a PD unit was independently associated with a higher risk of S. aureus peritonitis (adjusted odds ratio [OR] 1.64, 95% CI 1.09-2.47). Distant patients with first peritonitis episodes were less likely to be hospitalised (64% vs 73%, p=0.008) and receive antifungal prophylaxis (4% vs 10%, p=0.01), but more likely to receive vancomycin-based antibiotic regimens (52% vs 42%, p,0.001). Using multivariable logistic regression analysis of peritonitis outcomes, distant patients were more likely to be cured with antibiotics alone (OR 1.55, 95% CI 1.03-2.24). All other ...

TY - JOUR. T1 - Prevention of peritonitis during continuous ambulatory peritoneal dialysis. AU - Oreopoulos, D. G.. AU - Vas, S.. AU - Khanna, R.. PY - 1983. Y1 - 1983. UR - http://www.scopus.com/inward/record.url?scp=0021056820&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0021056820&partnerID=8YFLogxK. M3 - Article. AN - SCOPUS:0021056820. VL - 3. JO - Peritoneal Dialysis International. JF - Peritoneal Dialysis International. SN - 0896-8608. IS - 3 SUPPL.. ER - ...

The invention provides an apparatus and method for storing and transporting peritoneal dialysate in dry or lyophilized form, and for forming a deliverable peritoneal dialysis solution therefrom. In one embodiment, a dry reagent bed, including reagents sufficient to produce a dialysis solution, is suspended in a diluent flow path through the apparatus housing. Continuous pressure on the reagent bed causes the bed to compact as it erodes when purified water is passed through the housing. The pressure ensures complete and even dissolution of the reagents. Through dry storage and simple dissolution, even in a home, the invention enables a wider variety of solution constituents, including reduced acid content and the use of bicarbonate as a stable buffer component. The latter is illustrated in a double-bed embodiment, where bicarbonate is stored separately from calcium or magnesium salts within a single housing.

kidney information, kidney education, Types of Dialysis, dialysis meaning, dialysis machine, dialysis cost, dialysis types, dialysis procedure, kidney dialysis machine, dialysis side effects, dialysis tubing, dialysis definition, dialysis technician, Hemodialysis - Dialyser, Process of hemodialysis, renal dialysis, Peritoneal Dialysis, Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis-CAPD, Continuous Cycling Peritoneal Dialysis, Automated, peritoneal dialysis, CAPD Complications, CAPD Advantages, CAPD disadvantages, Hemodialysis, AV Fistula, Process of CAPD, dialysis, kidney dialysis diet, what is hemodialysis, kidney dialysis treatment, kidney failure and dialysis, diet for dialysis patients, what is kidney dialysis, what is dialysis, kidney dialysis

Peritoneal dialysis solutions are the basis for the treatment of peritoneal dialysis. Did you know that: PD fluids are pharmaceuticals? underlie the regulation ...

Adrian Dan, MD, Andrew B Standerwick, MD, Shayda Mirhaidari, MD, John Zografakis, MD. Summa Health Systems, Northeast Ohio Medical University. Introduction - The purpose of this study is to evaluate the short term outcomes of 100 patients undergoing laparoscopic peritoneal dialysis catheter placement using the combination of described techniques for optimal placement.. Methods and Procedures - One hundred laparoscopic PD catheter placements were attempted over 5 years. Technique included placement of an adhesive betadine drape and betadine catheter site irrigation to avoid infection, use of fascia and muscle separating trocars to prevent hernia formation, preperitoneal catheter tunneling, omentopexy to the RUQ with trans-abdominal sutures, suture anchoring of the catheter to the lower midline, and flushing with heparinized saline. Patient demographics and short term complications or failures were recorded.. Results - Ninety-six catheters were successfully placed in 100 patients. Mean age of the ...

百特含4.25％葡萄糖低鈣（2.5 mEq/L）腹膜透析液 DIANEAL LOW CALCIUM (2.5MEQ/L) PERITONEAL DIALYSIS SOLUTION WITH 4.25 DEXTROSE / 腹膜透析。 / 藥要看提供簡單的介面檢索國內有註冊登記的藥品資訊

Dianeal Low Calcium Peritoneal Dialysis Solution official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

1. We studied a total of 29 patients on continuous ambulatory peritoneal dialysis (CAPD), who had no present or past respiratory impairment, before and after drainage of dialysate (2.324 ± se 0.033 litres).. 2. We measured spirometry, lung volumes and carbon monoxide transfer sitting and supine in 20 patients. The only statistically significant changes on drainage were a small increase in supine functional residual capacity (+ 214 ± se 61 ml, P,0.01) and a small fall in supine peak expiratory flow rate (−26.6 ± se 12.1 litres/min, P,0.05).. 3. Measurement of maximal mouth and transdiaphragmatic pressures in ten patients made under the same circumstances showed no statistically significant changes on drainage.. 4. A model of the abdomen demonstrates that fluid distension is likely to be better tolerated than gaseous distension, and review of previous studies suggests that a wide range of changes in intraabdominal fluid volume can be tolerated without respiratory embarrassment.. 5. These ...

INTRODUCTION. Peritonitis is a major complication of peritoneal dialysis. Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus spp., Enterococcus faecalis and Escherichia coli are the most common causative pathogens for peritonitis.1 Guidelines recommend that selection of empiric therapy must cover both gram-positive and gram-negative microorganisms and a fourth-generation cephalosporin is a suitable agent. In addition a first-generation cefalosporin may be used with ceftazidime or aminoglycoside, if cefepime is not available. After causative organism is identified, treatment should be organized according to microorganism.2 Minimum length of therapy is two weeks, for severe infections the recommended treatment duration is three weeks.3 In literature Campylobacter peritonitis has been reported in adult patients. In this report we present the first pediatric case with C. jejuni peritonitis.. CASE REPORT. A 10-year-old boy with end stage renal failure secondary to atypical hemolytic ...

Learn about Extraneal (Icodextrin Peritoneal Dialysis Solution) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Peritoneal dialysis. Peritoneal dialysis is performed by surgically placing a special, soft, hollow tube into the lower abdomen near the navel. After the tube is placed, a special solution called dialysate is instilled into the peritoneal cavity. The peritoneal cavity is the space in the abdomen that houses the organs and is lined by two special membrane layers called the peritoneum. The dialysate is left in the abdomen for a designated period of time which will be determined by your doctor. The dialysate fluid absorbs the waste products and toxins through the peritoneum. The fluid is then drained from the abdomen, measured, and discarded. There are three different types of peritoneal dialysis: continuous ambulatory peritoneal dialysis (CAPD), continuous cyclic peritoneal dialysis (CCPD), and intermittent peritoneal dialysis (IPD ...

This study shows that, for Gram-positive and culture-negative PD-associated peritonitis, increasing residual kidney function is associated with increasing odds of peritonitis treatment failure. This observation is consistent with the hypothesis that greater residual kidney function allows for more clearance of antibiotics by the kidneys, which in turn, leads to lower blood and subsequent intraperitoneal antibiotic concentrations and therefore, higher risk of treatment failure. Previous studies and the ISPD guidelines have generally dichotomized residual kidney function as either present or absent (7-9). This study focused on the varying degrees of urinary creatinine clearance, especially those with clearances ,5 ml/min.. Clearance of antibiotic by the kidneys contributes significantly to total clearance. Prior studies have shown that there is a positive correlation between urinary creatinine clearance and the clearance of cefazolin (7), vancomycin (8), tobramycin (7), and ceftazidime (9). In ...

Continuous Ambulatory Peritoneal Dialysis (CAPD) is the most common form of peritoneal dialysis. The dialysis happens daily inside of your body. You need to change the dialysis fluid several times during the day and this can be done at home or at wor

Definition of Continuous ambulatory peritoneal dialysis with photos and pictures, translations, sample usage, and additional links for more information.

Thierry Lobbedez is a staff nephrologists at the Nephrology Department of the University Hospital of Caen recognized in France for his Peritoneal Dialysis Programme. After his Nephrology training he was recruited to the Nephrology Department of the University of Caen. Thereafter he was a clinical fellow in Toronto under Dimitrios Oreopoulos. Upon returning to Caen, he became an active member of the French Peritoneal Dialysis Registry. His field of interest is the integration of PD in the different options used to treat end stage renal disease. Currently he is in charge with the PD Programme at the Hospital of Caen where he has a Professor position.. ...

Author: Allen Loyd V Jr, Year: 1999, Abstract: A formulation for preparing Vancomycin and Ceftazidime in Peritoneal Dialysis Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

The Market Research Store report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Peritoneal Dialysis Solution market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing…

PubMed journal article: Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Download Prime PubMed App to iPhone, iPad, or Android

Press Release issued Dec 6, 2017: Dialysis refers to the process of cleaning the blood in case of kidney failure or improper functioning of kidneys. There are two types of dialysis; hemodialysis and peritoneal dialysis. Hemodialysis involves pumping out of the blood to an artificial kidney system and is returned back to the body with the help of tubing accessories. Peritoneal dialysis involves the cleansing of blood along with removal of extra fluids by utilizing bodys natural filter, the peritoneal membrane. Peritoneal membrane is the lining that surrounds the abdominal cavity comprising spleen, stomach, liver and intestines.

Studies of outcomes associated with dialysis therapies have yielded conflicting results. Bloembergen et al showed that prevalent patients on continuous ambulatory peritoneal dialysis (CAPD) or continuous cycling peritoneal dialysis (CCPD) had a 19% higher mortality risk than hemodialysis patients, a …

Given the fundamental role that the kidney has in the maintenance of homeostasis, it is not uncommon to observe the appearance of water and electrolytic disorders in patients who suffer from chronic terminal renal failure. In the case of patients undergoing peritoneal dialysis, due to the particular aspects which are characteristic of this dialytic modality, there is a series of hydro-electrolytic problems which are more frequently detected in this subgroup of patients: hydrosaline retention, hypokalemia, hypermagnesemia, and respiratory alkalosis. Regarding hydrosaline retention, it is observed when water and salt intake exceeds its urinary and/or dialytic excretion. The latter is observed when there is scarce ultrafiltration, be it due to an inadequate dialytic strategy or to stress of the peritoneal membrane. Concerning hypokalemia, it can be observed up to 30% of the peritoneal dialysis patients, originating from the effect of the released insulin due to the glucose absorbed from the ...

Background. Peritoneal mesothelial cells play an important role in peritoneal dialysis and are often exposed to dialysis fluid containing high glucose levels. Loss of peritoneal function is a major complication associated with long-term peritoneal dialysis. In this study, we hypothesized that high glucose levels induce apoptosis, and that insulin attenuates this apoptosis in peritoneal mesothelial cells. To clarify this hypothesis, we examined the effects of insulin on the phosphatidylinositol 3-kinase/Akt signaling pathway and apoptosis in rat peritoneal mesothelial cells.. Methods. Phosphorylated insulin receptor and Akt were detected by western blot analysis. Apoptosis was evaluated by measuring caspase 3 activity and by TUNNEL staining.. Results. Insulin (100 nmol/L) increased tyrosine phosphorylation of insulin receptor in peritoneal mesothelial cells. Furthermore, insulin (1-100 nmol/L) dose-dependently stimulated Akt phosphorylation. Treatment with the phosphatidylinositol 3-kinase ...

Image Source: Google. Hemodialysis and peritoneal dialysis are kinds of dialysis therapy that replace the function of the failing kidneys by essentially filtering the waste products in the bloodstream.. The fundamental difference between hemodialysis and peritoneal dialysis is that hemodialysis uses a system - artificial kidney - to filter the blood while peritoneal dialysis uses the bodys own peritoneal membrane thats situated in the abdomen.. The decision about what method is selected is based upon several factors such as the medical conditions and lifestyle of the person. Hem dialysis is typically performed at a dialysis facility outside of a hospital while peritoneal dialysis can be performed at home.. Complications can occur with both processes with the most common problem related to hemodialysis being vascular access issues, and the most common problem related to peritoneal dialysis being severe abdominal infection.. In certain circumstances where the kidneys have failed, the ...

Handbook of Peritoneal Dialysis | Handbook of Peritoneal DialysisSecond EditionSteven Guest M.D. This book is a guide to the clinical practice of Peritoneal Dialysis. Chapters provide the core curriculum for expertise in PD therapy and address relevant clinical challenges faced by caregivers.

EMT is a complex, stepwise phenomenon that occurs during embryonic development and tumor progression (Thiery et al., 2009), and is also associated with chronic inflammatory and fibrogenic diseases affecting lung, liver and the peritoneum of patients undergoing peritoneal dialysis (Kalluri and Weinberg, 2009; Aroeira et al., 2007). During dialysis, the peritoneum is exposed to continuous inflammatory stimuli such as hyperosmotic, hyperglycemic and acidic dialysis solutions, as well as episodes of peritonitis and hemoperitoneum, which might cause acute and chronic inflammation and progressively lead to fibrosis, angiogenesis and hyalinizing vasculopathy. Our previous work demonstrated that effluent-derived mesothelial cells (MCs) from peritoneal dialysis patients show phenotypic changes, reminiscent of EMT, which are associated with the time of peritoneal dialysis treatment and with episodes of peritonitis or hemoperitoneum (Yanez-Mo et al., 2003). Moreover, the appearance of EMT signs correlates ...

Covid Impact on Asia and North Africa Hemodialysis & Peritoneal Dialysis Market, growth/decline in product type/use cases of Asia and North Africa Hemodialysis & Peritoneal Dialysis Market due to cascaded impact of Covid on Extended Ecosystem ...

Isolated case reports of peritonitis due to Brucella spp. during peritoneal dialysis (PD) continue to surface in the medical literature. However, the optimal treatment regimen for these patients, in particular with regards to the fate of PD catheter, is still largely unknown. We report a case of brucella peritonitis successfully treated with intraperitoneal administration of amikacin, along with oral rifampicin and doxycycline but without catheter removal. Furthermore, we have reviewed the literature up until present day.

Health Related Articles and News - Dialysis / Haemodialysis / Continuous Ambulatory Peritoneal Dialysis Support Group - Kidney and bladder. Discuss with people facing the same health challenges as yours and seek online advice from experts.

International Journal of Nephrology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focusing on the prevention, diagnosis, and management of kidney diseases and associated disorders. The journal welcomes submissions related to cell biology, developmental biology, genetics, immunology, pathology, pathophysiology of renal disease and progression, clinical nephrology, dialysis, and transplantation.

We offer dialysis at home, including both home hemodialysis and peritoneal dialysis and the necessary training. Dialysis at home offers our patients many benefits over traditional in-center hemodialysis including ...

Peritoneal dialysis process involves the insertion of a tube into the patients stomach to carry out dialysis process. In PD, a catheter is used to carry out dialysis using a flow of a sterile fluid through the lining of the abdomen, the peritoneum. This helps the blood flow to pass in and out of the peritoneal space. This process is used to remove waste products and fluid from the body in patients with severe renal diseases. Peritoneal dialysis is two types: continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD).. Technavios analysts forecast the global peritoneal dialysis market to grow at a CAGR of 5.45% during the period 2016-2020.. ...

Dialysis nurses are certified in BLS (Basic Life Support, at the Provider Level) and frequently, Hemodialysis Administration. Nurses may perform both kidney and peritoneal dialysis, although kidney dialysis is the most common. Nurses may work in the hospital or at local dialysis centers. Patients are most frequently on dialysis on a permanent basis because of kidney failure, although dialysis may also be short-term for temporarily compromised kidney functioning. Nurses working on a dialysis unit access a surgically-placed fistula located on the patients arm. Patients who are long-time dialysis patients frequently have one fistula stop working and may require a second to be placed. The dialysis nurse is responsible for assessment of a patent fistula site. Throughout administration of dialysis, the nurse will be assessing the patients vital signs closely. A spike in temperature, a low blood pressure or heart rate is immediate cause for dialysis to be discontinued. A close relationship with ...

In peritoneal dialysis the abdomen is filled with a glucose-based liquid through a small hole created in the peritoneal membrane (lining of the abdominal cavity). This solution cleans the blood of wastes. Peritoneal dialysis can be done when the patient is performing regular activities. Such dialysis is called Continuous Ambulatory Peritoneal Dialysis. The patient will be trained to infuse and drain out the fluid a few times every day. Peritoneal dialysis can also be done with the help of a machine, at night when the patient is sleeping. Our Nephrology unit is running a Maintenance Hemodialysis program for last 4 years performing over 800 dialysis sessions a month with 8 stand in Machines We are also equipped with therapies like Plasmapherisis, Hemofiltration, for both Nephrological & non Nephrological indication. The stringent infection control practices, immunosuppressive protocols and proactive vigil for complications and their prompt management make the service a huge success. ...

Peritoneal Dialysis CAPD Channel: Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics. Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations, plus audio lectures with synchronized slide/audio presentations using Real Media. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and

Peritoneal Dialysis CAPD Channel: Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics. Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations, plus audio lectures with synchronized slide/audio presentations using Real Media. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and

This report analyzes the worldwide markets for Kidney Dialysis Equipment and Supplies in US$ by the following Segments: Hemodialysis (Hemodialysis Machines, Blood Pumps, Catheters, Dialyzers, Dialysates, Dialysis Tubing Kits, & Other Supplies), and Peritoneal Dialysis (Peritoneal Dialysis Cycler Machines, Peritoneal Tubing Kits, Dialysates, & Catheters). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 73 companies including many key and niche players such as ...

TY - JOUR. T1 - Cardiovascular problems in dialysis patients. T2 - impact on survival.. AU - Sidhu, Manavjot S.. AU - Dellsperger, Kevin C. PY - 2010/12/1. Y1 - 2010/12/1. N2 - Cardiovascular diseases, in their broad spectrum, are collectively the major cause of death in patients on dialysis. The population of patients treated with peritoneal and hemodialysis are not only subject to the traditional risk factors for heart disease, but also to certain uremia-associated risk factors that are unique in this population. Limited data are available on the effectiveness of routine interventions on cardiovascular outcomes in dialysis patients. Because most dialysis patients are excluded from clinical trials, data from randomized controlled trials regarding outcomes in patients undergoing peritoneal dialysis are almost absent. The present review discusses some of the major cardiovascular problems in the dialysis population, the impact of those problems on survival, and the available therapeutic ...

Drs. Chan and Siu reviewed the data on warfarin for patients with atrial fibrillation (AF) on dialysis. They argued that one of the merits of the study by Shah et al. (1) was the high prevalence of warfarin users and that one of the merits of our study was that we were able to distinguish between patients on hemodialysis and patients on peritoneal dialysis. Unfortunately, consensus on this important subject has not yet been reached, and the prevalence of warfarin usage among patients with AF and severe chronic kidney disease varies among countries and among clinics. In a recent Swedish study of patients with post-myocardial infarction AF (2), only 66 of 478 patients (13.8%) with an estimated glomerular filtration rate of ,16 ml/min/1.73 m2 received warfarin at baseline compared with 46.0% of dialysis patients in the study by Shah et al. (1).. We agree that the net clinical benefit of warfarin may be different in patients with AF on peritoneal dialysis than patients with AF on hemodialysis. Most ...

Home hemodialysis (HHD) has many benefits, but less is known about relative outcomes when comparing different home-based hemodialysis modalities. Here, we compare patient and treatment survival for patients receiving short daily HHD (2-3 hours/5 plus sessions per week), nocturnal HHD (6-8 hours/5 plus sessions per week) and conventional HHD (3-6 hours/2-4 sessions per week). A nationally representative cohort of Canadian HHD patients from 1996-2012 was studied. The primary outcome was death or treatment failure (defined as a permanent return to in-center hemodialysis or peritoneal dialysis) using an intention to treat analysis and death-censored treatment failure as a secondary outcome ...